Retatrutide

Investigational GIP / GLP-1 / Glucagon Receptor Agonist

Overview

Retatrutide is an investigational synthetic peptide studied for activity at the GIP, GLP-1, and glucagon receptors.

Current research examines receptor signaling, glucose homeostasis, metabolic pathways, energy balance, and related physiological mechanisms.



Research Focus

  • GIP, GLP-1, and glucagon receptor signaling

  • Glucose and metabolic pathway research

  • Energy-balance mechanisms

  • Substrate utilization

  • Metabolic signaling

Product Specifications

Form: Lyophilized peptide
In-Stock Strengths: 10 mg, 20 mg, 30 mg
Special-Order Strengths: 5 mg, 15 mg, 40 mg, 50 mg, 60 mg

Special Orders

Additional strengths may be available by special order. Availability, pricing, and lead times are subject to confirmation.

Storage

Store refrigerated at 2–8°C, unless otherwise specified.

Research Use Only

For laboratory and research applications only. Not intended for human or veterinary use, consumption, diagnosis, treatment, or clinical application.

Toronto-Based • Expanding Canada-Wide
Serving Vancouver & Beyond

© 2026 IZA Biosciences. All rights reserved.

For Research Use Only. Products offered by IZA Biosciences are intended exclusively for laboratory and research purposes. They are not intended for human or veterinary use, consumption, diagnosis, treatment, cure, or prevention of any disease. Purchasers are responsible for ensuring that all products are handled and used in accordance with applicable laws, regulations, and institutional requirements.